AU7667398A - Integrin-targeting vectors having transfection activity - Google Patents

Integrin-targeting vectors having transfection activity

Info

Publication number
AU7667398A
AU7667398A AU76673/98A AU7667398A AU7667398A AU 7667398 A AU7667398 A AU 7667398A AU 76673/98 A AU76673/98 A AU 76673/98A AU 7667398 A AU7667398 A AU 7667398A AU 7667398 A AU7667398 A AU 7667398A
Authority
AU
Australia
Prior art keywords
integrin
transfection activity
targeting vectors
nucleic acid
component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU76673/98A
Other languages
English (en)
Inventor
Stephen Lewis Hart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCL Institute of Child Health
Original Assignee
UCL Institute of Child Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCL Institute of Child Health filed Critical UCL Institute of Child Health
Publication of AU7667398A publication Critical patent/AU7667398A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y10S977/907—Liposome

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Electrotherapy Devices (AREA)
  • Compression Or Coding Systems Of Tv Signals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU76673/98A 1997-05-29 1998-05-29 Integrin-targeting vectors having transfection activity Abandoned AU7667398A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9711115.7A GB9711115D0 (en) 1997-05-29 1997-05-29 Integrin-targeting vectors having enhanced transfection activity
GB9711115 1997-05-29
PCT/GB1998/001577 WO1998054347A1 (en) 1997-05-29 1998-05-29 Integrin-targeting vectors having transfection activity

Publications (1)

Publication Number Publication Date
AU7667398A true AU7667398A (en) 1998-12-30

Family

ID=10813246

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76673/98A Abandoned AU7667398A (en) 1997-05-29 1998-05-29 Integrin-targeting vectors having transfection activity

Country Status (9)

Country Link
US (2) US6458026B1 (enExample)
EP (1) EP1003898B1 (enExample)
JP (1) JP4293292B2 (enExample)
AT (1) ATE301722T1 (enExample)
AU (1) AU7667398A (enExample)
CA (1) CA2288840A1 (enExample)
DE (1) DE69831156T2 (enExample)
GB (1) GB9711115D0 (enExample)
WO (1) WO1998054347A1 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1272507E (pt) 2000-04-12 2005-11-30 Amersham Health As Derivados de peptidos para ligacao a integrina
WO2001092543A2 (en) * 2000-05-30 2001-12-06 Ich Productions Limited Improved methods of transfection
EP1178117A1 (en) * 2000-08-02 2002-02-06 Erasmus Universiteit Rotterdam Targeting through integrins
NO20004795D0 (no) 2000-09-26 2000-09-26 Nycomed Imaging As Peptidbaserte forbindelser
US8613907B2 (en) * 2000-10-12 2013-12-24 University Of Rochester Compositions that inhibit proliferation of cancer cells
GB0106315D0 (en) 2001-03-14 2001-05-02 Ich Productions Ltd Transfection complexes
US7514098B2 (en) * 2001-05-30 2009-04-07 The Board Of Trustees Of The Leland Stanford Junior University Use of targeted cross-linked nanoparticles for in vivo gene delivery
EP2347771A1 (en) 2001-07-10 2011-07-27 Ge Healthcare As Peptide-based compounds for targeted imaging
GB0210538D0 (en) * 2002-05-08 2002-06-19 Univ London Lipids and gene delivery
US7598421B2 (en) 2002-05-08 2009-10-06 Ucl Biomedica Plc Materials for the delivery of biologically-active material to cells
CA2523413A1 (en) * 2003-04-25 2004-11-11 The Penn State Research Foundation Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
GB0313132D0 (en) * 2003-06-06 2003-07-09 Ich Productions Ltd Peptide ligands
US20090123468A1 (en) 2003-10-24 2009-05-14 Gencia Corporation Transducible polypeptides for modifying metabolism
ES2411962T3 (es) 2003-10-24 2013-07-09 Gencia Corporation Métodos y composiciones para suministrar polinucleótidos
US8507277B2 (en) 2003-10-24 2013-08-13 Gencia Corporation Nonviral vectors for delivering polynucleotides
US8133733B2 (en) 2003-10-24 2012-03-13 Gencia Corporation Nonviral vectors for delivering polynucleotides to target tissues
US8062891B2 (en) 2003-10-24 2011-11-22 Gencia Corporation Nonviral vectors for delivering polynucleotides to plants
EP1986698A2 (en) * 2006-02-01 2008-11-05 The Johns Hopkins University Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders
US10034674B2 (en) * 2006-02-02 2018-07-31 Steven C Chudik Universal anterior cruciate ligament repair and reconstruction system
GB0610636D0 (en) 2006-05-30 2006-07-05 Univ London Materials and complexes for the delivery of biologically-active material to cells
CN102317303A (zh) * 2007-07-31 2012-01-11 约翰·霍普金斯大学 用于肿瘤或感染性疾病的免疫预防或免疫治疗的多肽-核酸偶联物
AU2009206212B2 (en) 2008-01-24 2014-01-16 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Lytic domain fusion constructs and methods of making and using same
CN102265158A (zh) 2008-12-23 2011-11-30 通用电气健康护理有限公司 99mTc肽基化合物作为骨髓成像剂的应用
EP4406963A3 (en) 2015-08-28 2025-04-02 Molecular Transfer, Inc. Transfection complexes and methods of using the same
US10538784B2 (en) 2016-03-01 2020-01-21 Molecular Transfer, Inc. Plant virus movement proteins and methods of using the same
GB201604235D0 (en) 2016-03-11 2016-04-27 Ucl Business Plc Lipids and complexes for the delivery of biologically-active material to cells
GB201803419D0 (en) * 2018-03-02 2018-04-18 Ucl Business Plc Complex for the delivery of cas9 proteins guide RNA to cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981478A (en) * 1993-11-24 1999-11-09 La Jolla Cancer Research Foundation Integrin-binding peptides
WO1996015811A1 (en) 1994-11-17 1996-05-30 Imperial College Of Science, Technology & Medicine Internalisation of dna, using conjugates of poly-l-lysine and an integrin receptor ligand
JP4338106B2 (ja) 1995-06-07 2009-10-07 ライフ テクノロジーズ コーポレーション ペプチド増強カチオン脂質トランスフェクション
US5908777A (en) 1995-06-23 1999-06-01 University Of Pittsburgh Lipidic vector for nucleic acid delivery

Also Published As

Publication number Publication date
ATE301722T1 (de) 2005-08-15
US6458026B1 (en) 2002-10-01
US20020042384A1 (en) 2002-04-11
JP4293292B2 (ja) 2009-07-08
WO1998054347A1 (en) 1998-12-03
EP1003898A1 (en) 2000-05-31
EP1003898B1 (en) 2005-08-10
DE69831156D1 (de) 2005-09-15
DE69831156T2 (de) 2006-06-08
GB9711115D0 (en) 1997-07-23
US20030013644A1 (en) 2003-01-16
JP2002502243A (ja) 2002-01-22
CA2288840A1 (en) 1998-12-03

Similar Documents

Publication Publication Date Title
AU7667398A (en) Integrin-targeting vectors having transfection activity
CA2166931A1 (en) Electrostatic bonding type macromolecular micelle drug carrier and drug carried thereon
AU7489896A (en) Feed enzyme preparations
AU5671096A (en) Methods, nucleotide sequences and host cells for assaying ex ogenous and endogenous protease activity
AU2023199A (en) Methods, systems, and kits for intravascular nucleic acid delivery
AU5153296A (en) Vectors for gene delivery
AU3739697A (en) Gene delivery system
AU2946295A (en) Targeted gene delivery system
AU2537795A (en) Transformation systems for the yeast candida utilis and the expression of heterologous genes therewith
AU5044300A (en) Methods, concepts and technology for a virtual shopping system capable of assessing needs of a customer and recommending a product or service based on such assessed needs
AU2284697A (en) Fusogenic liposomes
PL327984A1 (en) Complementary systems of adenoviral vectors and cell lines
AU7908298A (en) Endo-beta-1,4-glucanases from (saccharothrix)
WO1995013095A3 (en) Therapy
WO2001049266A3 (en) Iron chelator delivery system
AU1124699A (en) Liposomal oligonucleotide compositions for modulating ras gene expression
CA2278808A1 (en) Methods for cultivating cells and propagating viruses
AU4330796A (en) Anti-neurodegeneratively active 10-aminoaliphatyl-dibenz(b,f)oxepines
AU1165899A (en) Conjugates comprising two active agents
AU4401297A (en) Improved retroviral vectors for gene therapy
AU6977898A (en) Strategic marketing system
WO2001092542A8 (en) Integrin-targeting vectors having enhanced transfection activity
AU6161698A (en) Methods for identifying, characterizing, and evolving cell-type specific cis regulatory elements
CA2302551A1 (en) .beta.-fructofuranosidase and its gene
AU3877395A (en) Enzyme gene therapy catalysing prodrug extracellular conversion

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase